Prolymphocytic Leukemia

• CLINICAL_TRIALS trial_result · 2016-01-18
  Clinical Trial Update: Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) [Phase 2]

  A Phase I/II trial of the gold compound auranofin in chronic lymphocytic leukemia and related lymphoid conditions has completed its Phase 2 …

• CLINICAL_TRIALS trial_result · 2015-11-11
  Clinical Trial Update: Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]

  This is a Phase 1 clinical trial update reporting results for Cyclophosphamide, Alvocidib, and Rituximab in high-risk B-cell chronic lymphoc…

• CLINICAL_TRIALS trial_result · 2015-11-04
  Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia [Phase 1]

  Phase 1 trial of Alvespimycin hydrochloride in relapsed/refractory B-cell chronic lymphocytic leukemia, prolymphocytic leukemia, and small l…

• CLINICAL_TRIALS research · 2015-09-29
  Clinical Trial Update: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy [Phase 1, Phase 2]

  Clinical trial update describing a Phase 1/Phase 2 study of a genetically engineered lymphocyte therapy for chemotherapy-resistant or refrac…

• CLINICAL_TRIALS trial_result · 2015-04-16
  Clinical Trial Update: Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL [Phase 1, Phase 2]

  Phase 1/2 trial results evaluate the efficacy and safety of combining ibrutinib (PCI-32765) with ofatumumab in B-cell chronic lymphocytic le…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-04-02
  Clinical Trial Update: Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]

  Phase 1 trial evaluating lenalidomide with alvocidib in relapsed or refractory B-cell chronic lymphocytic leukemia and small lymphocytic lym…

• CLINICAL_TRIALS trial_result · 2014-06-19
  Clinical Trial Update: AZD6738 First Time in Patient Multiple Ascending Dose Study [Phase 1]

  AZD6738 (berzosertib) was studied in a first-in-patient, multiple ascending-dose Phase 1 trial in relapsed/refractory hematologic cancers in…

• CLINICAL_TRIALS trial_result · 2014-01-09
  Clinical Trial Update: Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia [NA]

  This clinical trial update reports compassionate-use treatment with Campath-1H (alemtuzumab) for patients with refractory prolymphocytic leu…

• CLINICAL_TRIALS trial_result · 2013-09-30
  Clinical Trial Update: Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia [Phase 1]

  Phase 1 trial update of obatoclax, fludarabine, and rituximab in previously treated chronic lymphocytic leukemia; the study was terminated.

• CLINICAL_TRIALS trial_result · 2013-06-04
  Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia [Phase 1]

  A Phase 1 trial of tanespimycin (17-N-allylamino-17-demethoxygeldanamycin) with or without rituximab in relapsed B-cell chronic lymphocytic …

• CLINICAL_TRIALS trial_result · 2013-02-01
  Clinical Trial Update: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia [NA]

  A clinical trial evaluated arsenic trioxide in patients with relapsed or refractory lymphoma and leukemia; the study status is terminated.

• CLINICAL_TRIALS trial_result · 2011-08-29
  Clinical Trial Update: Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL [Phase 1, Phase 2]

  A Phase 1/2 study evaluating oxaliplatin, fludarabine, cytarabine, and rituximab in Richter's syndrome and refractory chronic lymphocytic le…

• CLINICAL_TRIALS trial_result · 2010-06-22
  Clinical Trial Update: BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma [Phase 1]

  Phase 1 trial of BL22 immunotoxin in patients with refractory chronic lymphocytic leukemia, prolymphocytic leukemia, and non-Hodgkin lymphom…

• CLINICAL_TRIALS research · 2007-04-17
  Clinical Trial Update: Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease [Phase 1]

  Phase 1 safety study evaluating CAT-8015 immunotoxin in patients with chronic lymphocytic leukemia, prolymphocytic leukemia, or small lympho…